SCHEMBL2764151

SCHEMBL2764151

Nc1ccccc1Nc1ccc(Br)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.70
KDM4E B2RXH2 3/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
TP53 P04637 1/20 0.70
APP P05067 1/20 0.70
HPGD P15428 1/20 0.70
ALOX15 P16050 1/20 0.70
SNCA P37840 1/20 0.70
BLM P54132 1/20 0.70
HSD17B10 Q99714 1/20 0.70
GAA P10253 4/20 0.69
ALDH1A1 P00352 4/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
LMNA P02545 1/20 0.69
CYP1A2 P05177 1/20 0.69
CYP2D6 P10635 1/20 0.69
CYP2C9 P11712 1/20 0.69
CYP2C19 P33261 1/20 0.69
TDP1 Q9NUW8 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4607773 0.89 MAPT (0.86) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL1636651 0.83 MAPT (1.00) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL4647245 0.83 MAPT (0.76) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL9396738 0.83 MAPT (0.91) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL217480 0.82 MAPT (1.00) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL29388147 0.82 MAPT (1.00) MAPTKDM4ESMN1; SMN2TP53APP
Methane SCHEMBL28002603 0.81 MAPT (0.96) MAPTKDM4ESMN1; SMN2TP53APP
Methane SCHEMBL4054340 0.80 MAPT (0.95) MAPTKDM4ESMN1; SMN2TP53APP
SCHEMBL6576141 0.80 MAPT (0.95) MAPTKDM4ESMN1; SMN2TP53APP
Hydrochloric Acid SCHEMBL29809096 0.80 MAPT (0.95) MAPTKDM4ESMN1; SMN2TP53APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106831864-B Based on phenylbenzimidazol monopole thermal excitation delayed fluorescence main body, the preparation method and application of electron transport material 黑龙江大学 2019-04-19 CN claimed
CN-106831864-A Based on phenylbenzimidazol monopole thermal excitation delayed fluorescence main body, the preparation method and application of electron transport material 黑龙江大学 2017-06-13 CN claimed
US-20230309380-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-28 US disclosed
US-11665961-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2023-05-30 US disclosed
US-20230120308-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-04-20 US disclosed
EP-4124619-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND Idemitsu Kosan Co., Ltd. (JP) 2023-02-01 EP disclosed
CN-111747933-B Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2022-03-01 CN disclosed
CN-111747937-B 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2022-01-14 CN disclosed
US-10825994-B2 Organic light emitting device and preparation method thereof Wuhan China Star Optoelectronics Technology, Ltd. (CN) 2020-11-03 US disclosed
CN-111747937-A 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 CN disclosed
CN-111747933-A Substituted 1,3, 5-triazine compound, composition and application thereof 吉林省元合电子材料有限公司 2020-10-09 CN disclosed
CN-101176219-A Polymer composition for organic electroluminescence SUMITOMO CHEMICAL CO (JP) 2008-05-07 CN disclosed
US-20070282076-A1 Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds BASF AKTIENGESELLSCHAFT (DE) 2007-12-06 US disclosed
US-20070282076-A1 Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds BASF AKTIENGESELLSCHAFT (DE) 2007-12-06 US disclosed
WO-2007135106-A1 PIPERIDINE DERIVATIVES AS HUMAN PAPILLOMA VIRUS INHIBITORS ANACONDA PHARMA (FR) 2007-11-29 WO disclosed
US-20070267970-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-11-22 US disclosed
US-20060147747-A1 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage IDEMITSU KOSAN CO., LTD. (JP) 2006-07-06 US disclosed
EP-1602648-A1 NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2005-12-07 EP disclosed
US-4009994-A Process and product of optical brightening with quaternized benzofuranyl-benzimidazoles CIBA-GEIGY CORPORATION (US) 1977-03-01 US disclosed
US-3940417-A Quaternised benzofuranyl-benzimidazoles CIBA-GEIGY CORPORATION (US) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230120308-A1 COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND ODC1, OR10J3, PIEZO1 MAPT 1600/4885KDM4E 1561/4885SMN1; SMN2 4493/4885
US-20070282076-A1 Transition Metal Carbene Complexes Embedded in Polymer Matrices for Use in Oleds OCIAD1, OCIAD2, PPID MAPT 525/4885KDM4E 3472/4885SMN1; SMN2 3108/4885
US-20230309380-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, OR10J3, TMEM109 MAPT 1419/4885KDM4E 3490/4885SMN1; SMN2 4064/4885
US-10825994-B2 Organic light emitting device and preparation method thereof CYBA, CYP1A2, CYP2B6 MAPT 2686/4885KDM4E 2469/4885SMN1; SMN2 4497/4885
US-20070267970-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME NUDC, NUDT1, SLC43A1 MAPT 2334/4885KDM4E 1640/4885SMN1; SMN2 4068/4885
US-11665961-B2 Heterocyclic compound and organic light emitting device using same CRY1, CYP1B1, CRY2 MAPT 2733/4885KDM4E 3112/4885SMN1; SMN2 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.